CytoDyn (CYDY) Convertible Debt (2011 - 2026)

CytoDyn's Convertible Debt history runs 14 years deep, the most recent figure standing at $27.2 million for Q1 2026.

• Quarterly Convertible Debt changed N/A year-over-year to $27.2 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $27.2 million (changed N/A YoY) and the FY2024 annual result came in at $45.0 million, down 1.55% from the prior year.
• Convertible Debt was $27.2 million for Q1 2026 at CytoDyn, down from $45.0 million in the prior quarter.
• Across five years, Convertible Debt topped out at $45.8 million in Q4 2023 and bottomed at $27.2 million in Q1 2026.
• A 4-year average of $42.2 million and a median of $44.9 million in 2023 frame the typical range for Convertible Debt.
• Annual changes were most pronounced in 2022 — Convertible Debt surged 65.65% — and 2024, when it declined 1.55%.
• CytoDyn's Convertible Debt stood at $42.2 million in 2022, then climbed by 8.61% to $45.8 million in 2023, then declined by 1.81% to $45.0 million in 2024, then tumbled by 39.58% to $27.2 million in 2026.
• Business Quant data shows CYDY's Convertible Debt at $27.2 million in Q1 2026, $45.0 million in Q2 2024, and $44.2 million in Q1 2024.